International Journal Of Clinical Pharmacology And Medical Sciences • pp. 1-12
CLINICAL EVALUATION OF DRUG SAFETY AND ADVERSE REACTIONS
Abstract
Drug safety is an essential component of modern clinical pharmacology because the appropriate use of medications
directly influences patient health, treatment effectiveness, and overall healthcare quality. Although pharmaceutical
treatments provide significant benefits in preventing and managing diseases, their use may also produce adverse
drug reactions that can negatively affect patients and create additional healthcare challenges. Adverse drug
reactions may occur because of inappropriate dosages, genetic variations, drug interactions, individual biological
characteristics, and unexpected responses to pharmaceutical substances. Clinical evaluation of drug safety involves
examining the benefits, risks, effectiveness, and possible complications associated with medication use. Modern
pharmacological research increasingly focuses on identifying potential safety concerns through clinical trials,
pharmacovigilance systems, laboratory investigations, and post-marketing surveillance. This research examines the
clinical evaluation of drug safety and adverse reactions, emphasizing their importance in improving patient
protection and strengthening rational medication practices. It also investigates the major causes of adverse drug
reactions, methods of identifying medication-related risks, and the role of healthcare professionals in preventing
avoidable complications. The study adopts a qualitative research methodology based on secondary academic
literature and published scientific investigations. The findings indicate that effective drug safety evaluation requires
continuous monitoring, accurate reporting, evidence-based prescribing, and cooperation among healthcare
professionals. Advanced technologies and improved pharmacovigilance systems can further strengthen the
identification and management of medication-related risks. However, underreporting, inadequate professional
awareness, complex drug interactions, and limitations in monitoring systems remain significant challenges. The
research concludes that comprehensive clinical evaluation and continuous pharmacovigilance are essential for
ensuring safer medication use and improving patient-centered healthcare.
Record
- Identifier
- https://doi-services.com/1141/232
- Published
- 2026-09-08
- Version
- 1